(PharmaNewsWire.Com, September 10, 2018 ) Nonsterile drug compounding is the practice of preparing specific medication doses for patients to drink, swallow, insert or apply to the skin. It is the most common kind of drug compounding done by pharmacists and pharmacy technicians in community and hospital pharmacies. And despite its "nonsterile" designation, making customized dosages according to legal and professional standards requires adhering to strict rules for ensuring and maintaining active pharmaceutical ingredient purity and potency; ensuring the accuracy of mixing; providing proper packaging, storage, and labeling; and keeping all work surfaces and equipment as clean as possible.
Simple nonsterile compounding involves mixing medications according to established formulas, or "recipes," and creating liquid versions of drugs usually sold only as tablets or capsules. Pediatricians and veterinarians often request these kinds of products for babies and animals who cannot swallow pills or need doses smaller than ones in commercially produced products. Moderate nonsterile compounding involves making dosages containing potentially harmful medications or preparations that require special handling.
A comprehensive analysis of the Global Non-Sterile Compounding Pharmacy Market is been done in this intelligence report. It includes the investigations done on the past progress, ongoing market scenarios, and future prospects. An accurate data of the products, strategies and market shares of leading companies in this particular market is mentioned.
This report studies the global Non-Sterile Compounding Pharmacy market, analyzes and researches the Non-Sterile Compounding Pharmacy development status and forecast five major reasons such as Global, EU, Japan, China, India and Southeast Asia.
The key players covered in this study Fagron B.Braun Melsungen Fresenius Kabi True Nature Holding Dougherty's Pharmacy Pharmedium ...
Market segment by Type, the product can be split into Oral Medication Topical Medications Otologic/Nasal Medication
Market segment by Application, split into Pain Management Hormone Replacement Therapy
Market segment by Regions/Countries, this report covers United States Europe China Japan Southeast Asia India Central & South America
12 International Players Profiles 12.1 Fagron 12.1.1 Fagron Company Details 12.1.2 Company Description and Business Overview 12.1.3 Non-Sterile Compounding Pharmacy Introduction 12.1.4 Fagron Revenue in Non-Sterile Compounding Pharmacy Business (2013-2018) 12.1.5 Fagron Recent Development 12.2 B.Braun Melsungen 12.2.1 B.Braun Melsungen Company Details 12.2.2 Company Description and Business Overview 12.2.3 Non-Sterile Compounding Pharmacy Introduction 12.2.4 B.Braun Melsungen Revenue in Non-Sterile Compounding Pharmacy Business (2013-2018) 12.2.5 B.Braun Melsungen Recent Development 12.3 Fresenius Kabi 12.3.1 Fresenius Kabi Company Details 12.3.2 Company Description and Business Overview 12.3.3 Non-Sterile Compounding Pharmacy Introduction 12.3.4 Fresenius Kabi Revenue in Non-Sterile Compounding Pharmacy Business (2013-2018) 12.3.5 Fresenius Kabi Recent Development
13 Market Forecast 2018-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2018-2025) 13.10 Market Size Forecast by Application (2018-2025)
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
